Aarti Pharmalabs Ltd. (AARTIPHARM) 52 Week High Streak: Second Straight Session Near One-Year Peak

Aarti Pharmalabs 52 Week High Streak has now continued for the second straight session, with the stock trading within 2% of its 52-week high and moving 7.68% across the streak. The latest high in this run stood at Rs 1,001.55, while the latest price was Rs 984.2. The latest Univest figures confirm the repeated-high pattern, but they do not establish a company-specific catalyst for why the stock has kept trading near its yearly peak.

The stock last traded at Rs 984.2 versus the previous close of Rs 973.3, after opening at Rs 991.55 and moving between Rs 981 and Rs 1,001.55 during the session. Aarti Pharmalabs Ltd. has a market capitalisation of Rs 8,288.13 crore. For readers tracking the Aarti Pharmalabs 52 Week High Streak, the key point is not a single-day move but the fact that the stock has stayed close to its one-year high for two sessions in a row.

Aarti Pharmalabs Ltd. 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 984.2
Previous Close	Rs 973.3
Today's Move	+Rs 10.9 (+1.12%)
Open	Rs 991.55
High	Rs 1,001.55
Low	Rs 981
Market Capitalisation	Rs 8,288.13 crore

Aarti Pharmalabs Ltd. (AARTIPHARM) traded at Rs 984.2 versus the previous close of Rs 973.3, a rise of 1.12%. The stock opened at Rs 991.55, reached a high of Rs 1,001.55 and touched a low of Rs 981.

Aarti Pharmalabs Ltd. share price today was Rs 984.2, up Rs 10.9 or 1.12% from the previous close of Rs 973.3. The stock opened above the last traded level, then moved through a narrow band that kept it close to the upper end of the range. The day’s high of Rs 1,001.55 is important because it shows how near the stock remained to its yearly peak while the Aarti Pharmalabs 52 Week High Streak continued.

The day low was Rs 981, so the stock spent the session near the upper half of the range rather than drifting far away from the higher band. That pattern matters more than a single percentage change because the Aarti Pharmalabs 52 Week High Streak is built on repeated proximity to the 52-week high, not on one isolated jump. The company’s market capitalisation of Rs 8,288.13 crore places the Aarti Pharmalabs share price in a market-followed zone where investors often compare valuation, earnings quality and sector positioning closely. For users searching Aarti Pharmalabs stock news or Aarti Pharmalabs stock performance, the current setup reflects persistence near the yearly peak rather than a one-off print.

What the Repeated 52-Week Highs Show

The Aarti Pharmalabs 52 Week High Streak shows that the stock has remained close to its one-year high for multiple sessions, with a 7.68% cumulative move across the streak. That cumulative figure is the most useful number for understanding the pattern because it captures the repeated high behaviour better than a single day’s gain. The latest high of Rs 1,001.55 also marks how closely the current price is tracking the 52-week peak.

For readers scanning stocks hitting 52 week highs, this pattern suggests continuity in the Aarti Pharmalabs share price rather than a brief spike. The data confirms the streak, but it does not confirm any company-specific catalyst. That distinction matters because the market can keep a stock near a yearly high for different reasons, and the available numbers alone only show the price pattern. In that sense, the Aarti Pharmalabs New One Year High theme is really a repeated-highs story, and the Aarti Pharmalabs Back To Back 52 Week Highs label fits the observed trading pattern more accurately than a single-session breakout narrative.

Aarti Pharmalabs Ltd. (AARTIPHARM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 8,288.13 crore
P/E Ratio	41.41x
P/B Ratio	4.03x
ROE	8.5%
ROCE	10.77%
EPS	Rs 23.51
Book Value Per Share	Rs 241.54
Dividend Yield	0.36%

Aarti Pharmalabs Ltd. (AARTIPHARM) fundamental metrics show P/E 41.41x, P/B 4.03x, ROE 8.5%, ROCE 10.77%. These figures provide context only and are not a buy or sell signal.

Aarti Pharmalabs Ltd. has a market capitalisation of Rs 8288.13 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 41.41x, P/B at 4.03x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.5% and ROCE of 10.77%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 23.51, book value per share of Rs 241.54, dividend yield of 0.36%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.2x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	41.41x
Benchmark Median P/E	28.2x
Benchmark Average P/E	42.01x
Benchmark P/E Range	0x to 699.02x
Company P/B Ratio	4.03x
Benchmark Median P/B	2.87x
Company ROE	8.5%
Benchmark Median ROE	11.74%
Company ROCE	10.77%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 8,288.13 crore
Benchmark Median Market Cap	Rs 773.14 crore

Aarti Pharmalabs Ltd. (AARTIPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 41.41x, which is above the benchmark median of 28.2x, a difference of +46.84%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROE of 8.5%, which is below the benchmark median of 11.74%, a difference of -27.6%. Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROCE of 10.77%, which is below the benchmark median of 13.63%, a difference of -20.98%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Supriya Lifescience Ltd.	SUPRIYA	7,922.73	39.94	6.48	19.06	25.3
Bliss GVS Pharma Ltd.	BLISSGVS	7,842.94	55.44	6.12	12.11	17.4
Sanofi Consumer Healthcare India Ltd.	SANOFICONR	8,902.83	33.47	25.59	73.2	98.11
Suven Life Sciences Ltd.	SUVEN	9,094.28	0	16.51	-101.8	-78.71
Innova Captab Ltd.	INNOVACAP	7,275.01	46.59	6.42	13.75	15.04

Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 41.41x compared with the displayed peer median of 39.94x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.5% compares with a peer median of 13.75% across the companies shown in the table. ROCE stood at 10.77% versus the displayed peer median of 17.4%, providing a capital-efficiency comparison. Aarti Pharmalabs Ltd. (AARTIPHARM) has a market capitalisation of Rs 8,288.13 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Aarti Pharmalabs

• Aarti Pharmalabs 52 Week High Streak has extended into a second straight session.
• The stock has moved 7.68% across the streak, which is the key cumulative figure for this run.
• The latest high of Rs 1,001.55 keeps the Aarti Pharmalabs share price near its one-year peak.
• The company’s P/E of 41.41 and P/B of 4.03 place valuation above the industry median.
• The Healthcare sector and Pharmaceuticals & Drugs industry remain central to any Aarti Pharmalabs Stock News review.

About Aarti Pharmalabs Ltd.

Aarti Pharmalabs Ltd. is listed on NSE and BSE and operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company has a market capitalisation of Rs 8,288.13 crore, an EPS of Rs 23.51, a book value of Rs 241.54 and a dividend yield of 0.36. In the current Aarti Pharmalabs 52 Week High Streak, the stock’s repeated trading near its yearly peak keeps it visible for market participants tracking pharmaceutical shares and broader Stock Price trends.

For readers following Aarti Pharmalabs Stock Analysis or Aarti Pharmalabs Share Price Today, the most relevant company snapshot is the balance between a higher valuation and modest return ratios. That combination often shapes how investors read the stock when it stays close to a one-year high for more than one session. The latest price action keeps Aarti Pharmalabs in the Stocks At One Year High Today conversation without turning the move into a separate event.

Frequently Asked Questions

What is the Aarti Pharmalabs 52 Week High Streak?

Ans. Aarti Pharmalabs 52 Week High Streak means the stock has traded within 2% of its 52-week high for two consecutive sessions. In the latest run, that streak has continued for the second straight session, keeping the Aarti Pharmalabs share price near its yearly peak.

How much has Aarti Pharmalabs moved across the streak?

Ans. The Aarti Pharmalabs 52 Week High Streak has seen a cumulative move of 7.68%. That is the best way to read the pattern because it captures the repeated proximity to the high across sessions rather than focusing only on one trading day.

Did Aarti Pharmalabs set a new 52-week high today?

Ans. The stock touched Rs 1,001.55, which is near the 52-week high zone, but the event described here is a repeated near-high pattern. The article should be read as a second straight session close to the yearly peak, not as a separate all-time or record-high claim.

What was Aarti Pharmalabs last traded price today?

Ans. Aarti Pharmalabs last traded at Rs 984.2, up Rs 10.9 or 1.12% from the previous close of Rs 973.3. The price stayed close to the upper part of the day’s range, which matters for readers following the Aarti Pharmalabs Share Price Today move.

How does Aarti Pharmalabs look on valuation?

Ans. Aarti Pharmalabs has a P/E ratio of 41.41 and a P/B ratio of 4.03. Both are above the industry median in the Pharmaceuticals & Drugs set shown here, so the Aarti Pharmalabs stock analysis points to a relatively richer valuation than many peers.

How do the return ratios compare with peers?

Ans. Aarti Pharmalabs reports ROE of 8.5 and ROCE of 10.77, both below the industry median in the comparable universe. That means the Aarti Pharmalabs Fundamental Analysis is not just about price levels; it also depends on return quality versus sector peers.

What sector does Aarti Pharmalabs belong to?

Ans. Aarti Pharmalabs belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That sector context is useful when comparing the stock’s market cap, valuation and return ratios with other healthcare names in the Aarti Pharmalabs peer set.

What should investors monitor next in Aarti Pharmalabs?

Ans. Investors should watch whether the stock continues to trade near its one-year high, how the Aarti Pharmalabs share price behaves versus the latest range, and whether future company updates change the current valuation and return profile. The repeated-high pattern is clear; the driver is not.

Track Aarti Pharmalabs Ltd. (AARTIPHARM) Share Price on Univest

Use Aarti Pharmalabs Ltd. (AARTIPHARM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.